glp-1 atrial fibrillation receptor agonists and myocardial metabolism in GLP‑1 Therapy Improves Atrial Fibrillation
Description
Weight Loss GLP-1 Tablets by Prime Human Labs contains FDA Approved Orforglipron (Orfo), an innovative oral GLP-1 compound gaining attention among individuals pursuing fat loss, cutting phases, and body composition improvements
Repatha (evolocumab) is a PCSK9 inhibitor that cuts LDL by ~60% when statins aren't enough
Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)
Hengrui agrees a $15.2bn R&D alliance with BMS in oncology/haematology and immunology, less than a year after a similar $12bn deal with GSK.
Researchers and leading pharma scientists now ask: could GLP-1s be our first true longevity drugs
